These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 33293690)
1. Targeting Notch in oncology: the path forward. Majumder S; Crabtree JS; Golde TE; Minter LM; Osborne BA; Miele L Nat Rev Drug Discov; 2021 Feb; 20(2):125-144. PubMed ID: 33293690 [TBL] [Abstract][Full Text] [Related]
2. Notch Signaling in Cancer: Rationale and Strategies for Targeting. Alketbi A; Attoub S Curr Cancer Drug Targets; 2015; 15(5):364-74. PubMed ID: 26239151 [TBL] [Abstract][Full Text] [Related]
3. Controversies in cancer stem cells: targeting embryonic signaling pathways. Takebe N; Ivy SP Clin Cancer Res; 2010 Jun; 16(12):3106-12. PubMed ID: 20530695 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic targets of triple-negative breast cancer: a review. Jamdade VS; Sethi N; Mundhe NA; Kumar P; Lahkar M; Sinha N Br J Pharmacol; 2015 Sep; 172(17):4228-37. PubMed ID: 26040571 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic modulation of Notch signalling--are we there yet? Andersson ER; Lendahl U Nat Rev Drug Discov; 2014 May; 13(5):357-78. PubMed ID: 24781550 [TBL] [Abstract][Full Text] [Related]
6. Targeting Notch to target cancer stem cells. Pannuti A; Foreman K; Rizzo P; Osipo C; Golde T; Osborne B; Miele L Clin Cancer Res; 2010 Jun; 16(12):3141-52. PubMed ID: 20530696 [TBL] [Abstract][Full Text] [Related]
8. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses. Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L Front Immunol; 2018; 9():1288. PubMed ID: 29915603 [TBL] [Abstract][Full Text] [Related]
9. Notch Signaling in Breast Cancer: A Role in Drug Resistance. BeLow M; Osipo C Cells; 2020 Sep; 9(10):. PubMed ID: 33003540 [TBL] [Abstract][Full Text] [Related]
10. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353 [TBL] [Abstract][Full Text] [Related]
11. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. Espinoza I; Miele L Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications. Li JL; Harris AL Front Biosci (Landmark Ed); 2009 Jan; 14(8):3094-110. PubMed ID: 19273260 [TBL] [Abstract][Full Text] [Related]
13. Notch signalling in cancer stem cells. Bolós V; Blanco M; Medina V; Aparicio G; Díaz-Prado S; Grande E Clin Transl Oncol; 2009 Jan; 11(1):11-9. PubMed ID: 19155199 [TBL] [Abstract][Full Text] [Related]
14. Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings. Goruganthu MUL; Shanker A; Dikov MM; Carbone DP Front Immunol; 2020; 11():1958. PubMed ID: 32922403 [TBL] [Abstract][Full Text] [Related]
15. Dichotomy of Notch signalling in regulating tumour immune surveillance. Khosla R; Vyas AK; Trehanpati N Scand J Immunol; 2019 Mar; 89(3):e12744. PubMed ID: 30548971 [TBL] [Abstract][Full Text] [Related]